To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: OncoMed, Vividion, Spero

Cancer company OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) said Chairman and CEO Paul Hastings began a medical leave of absence.

Proteomics company Vividion Therapeutics Inc. (San Diego, Calif.) named Diego Miralles CEO. He

Read the full 306 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE